Tag: Food & Drug Administration
FDA Approves Ocrevus to Treat Severe Form of Multiple Sclerosis
First drug sanctioned in United States for primary progressive multiple sclerosis
FDA Approves Zejula for Certain Female Cancers
PARP inhibitor may help fight tumors affecting the ovaries, fallopian tubes, or peritoneum
FDA Approves Bavencio for Merkel Cell Carcinoma
Drug targets the PD-1/PD-L1 pathway; first sanctioned treatment in the United States
FDA Approves New Parkinson’s Add-On Drug Xadago
To help prevent 'off' episodes among users of levodopa/carbidopa
FDA Approves Noctiva Nasal Spray for Nocturnal Polyuria
Drug designed to increase absorption of water through the kidneys, decreasing urine production
FDA Approves Odactra for House Dust Mite Allergies
Year-round, once-a-day tablet that's taken sublingually
FDA Approves Xermelo for Carcinoid Syndrome Diarrhea
Oral tablets to be used in combination with somatostatin analog therapy
FDA Approves Siliq for Plaque Psoriasis
Injected medication approved for use by patients who've failed other treatments
FDA Approves Emflaza for Duchenne Muscular Dystrophy
Approved to treat Duchenne muscular dystrophy in patients 5 years and older
FDA Approves Newborn Screening Tests for Metabolic Disorders
Screens used to detect Mucopolysaccharidosis Type 1, Pompe, Gaucher, and Fabry
